These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

371 related items for PubMed ID: 15276916

  • 1. Quantitative PCR--new diagnostic tool for quantifying specific mRNA and DNA molecules: HER2/neu DNA quantification with LightCycler real-time PCR in comparison with immunohistochemistry and fluorescence in situ hybridization.
    Schlemmer BO, Sorensen BS, Overgaard J, Olsen KE, Gjerdrum LM, Nexo E.
    Scand J Clin Lab Invest; 2004; 64(5):511-22. PubMed ID: 15276916
    [Abstract] [Full Text] [Related]

  • 2. Real-time RT-PCR analysis for evaluating the Her2/neu status in breast cancer.
    Cuadros M, Talavera P, López FJ, García-Peréz I, Blanco A, Concha A.
    Pathobiology; 2010; 77(1):38-45. PubMed ID: 20185966
    [Abstract] [Full Text] [Related]

  • 3. Real-time quantitative PCR of microdissected paraffin-embedded breast carcinoma: an alternative method for HER-2/neu analysis.
    Gjerdrum LM, Sorensen BS, Kjeldsen E, Sorensen FB, Nexo E, Hamilton-Dutoit S.
    J Mol Diagn; 2004 Feb; 6(1):42-51. PubMed ID: 14736826
    [Abstract] [Full Text] [Related]

  • 4. Expression of HER2 and the coamplified genes GRB7 and MLN64 in human breast cancer: quantitative real-time reverse transcription-PCR as a diagnostic alternative to immunohistochemistry and fluorescence in situ hybridization.
    Vinatzer U, Dampier B, Streubel B, Pacher M, Seewald MJ, Stratowa C, Kaserer K, Schreiber M.
    Clin Cancer Res; 2005 Dec 01; 11(23):8348-57. PubMed ID: 16322295
    [Abstract] [Full Text] [Related]

  • 5. Real-time PCR quantification of c-erbB-2 gene is an alternative for FISH in the clinical management of breast carcinoma patients.
    Suo Z, Daehli KU, Lindboe CF, Borgen E, Bassarova A, Nesland JM.
    Int J Surg Pathol; 2004 Oct 01; 12(4):311-8. PubMed ID: 15494857
    [Abstract] [Full Text] [Related]

  • 6. HER-2 DNA quantification of paraffin-embedded breast carcinomas with LightCycler real-time PCR in comparison to immunohistochemistry and chromogenic in situ hybridization.
    Ntoulia M, Kaklamanis L, Valavanis C, Kafousi M, Stathopoulos E, Arapantoni P, Mavroudis D, Georgoulias V, Lianidou ES.
    Clin Biochem; 2006 Sep 01; 39(9):942-6. PubMed ID: 16916505
    [Abstract] [Full Text] [Related]

  • 7. HER-2 gene amplification, HER-2 and epidermal growth factor receptor mRNA and protein expression, and lapatinib efficacy in women with metastatic breast cancer.
    Press MF, Finn RS, Cameron D, Di Leo A, Geyer CE, Villalobos IE, Santiago A, Guzman R, Gasparyan A, Ma Y, Danenberg K, Martin AM, Williams L, Oliva C, Stein S, Gagnon R, Arbushites M, Koehler MT.
    Clin Cancer Res; 2008 Dec 01; 14(23):7861-70. PubMed ID: 19047115
    [Abstract] [Full Text] [Related]

  • 8. HER-2/Neu alterations in non-small cell lung cancer: a comprehensive evaluation by real time reverse transcription-PCR, fluorescence in situ hybridization, and immunohistochemistry.
    Pellegrini C, Falleni M, Marchetti A, Cassani B, Miozzo M, Buttitta F, Roncalli M, Coggi G, Bosari S.
    Clin Cancer Res; 2003 Sep 01; 9(10 Pt 1):3645-52. PubMed ID: 14506153
    [Abstract] [Full Text] [Related]

  • 9. Comparison of HER2 status by fluorescence in situ hybridization and immunohistochemistry to predict benefit from dose escalation of adjuvant doxorubicin-based therapy in node-positive breast cancer patients.
    Dressler LG, Berry DA, Broadwater G, Cowan D, Cox K, Griffin S, Miller A, Tse J, Novotny D, Persons DL, Barcos M, Henderson IC, Liu ET, Thor A, Budman D, Muss H, Norton L, Hayes DF.
    J Clin Oncol; 2005 Jul 01; 23(19):4287-97. PubMed ID: 15994142
    [Abstract] [Full Text] [Related]

  • 10. Real-time reverse transcription-PCR and fluorescence in-situ hybridization are complementary to understand the mechanisms involved in HER-2/neu overexpression in human breast carcinomas.
    Vanden Bempt I, Vanhentenrijk V, Drijkoningen M, Wlodarska I, Vandenberghe P, De Wolf-Peeters C.
    Histopathology; 2005 Apr 01; 46(4):431-41. PubMed ID: 15810955
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. HER2 status in breast cancer determined by IHC and FISH: comparison of the results.
    Mrozkowiak A, Olszewski WP, Piaścik A, Olszewski WT.
    Pol J Pathol; 2004 Apr 01; 55(4):165-71. PubMed ID: 15757204
    [Abstract] [Full Text] [Related]

  • 14. Clinical significance of Caveolin-1, Caveolin-2 and HER2/neu mRNA expression in human breast cancer.
    Sagara Y, Mimori K, Yoshinaga K, Tanaka F, Nishida K, Ohno S, Inoue H, Mori M.
    Br J Cancer; 2004 Aug 31; 91(5):959-65. PubMed ID: 15305200
    [Abstract] [Full Text] [Related]

  • 15. Histological tumor grade correlates with HER2/c-erB-2 status in invasive breast cancer: a comparative analysis between immunohistochemical (CB11 clone and Herceptest), FISH and differential PCR procedures.
    López-Guerrero JA, Navarro S, Noguera R, Almenar S, Pellin A, Vázquez C, Llombart-Bosch A.
    Arkh Patol; 2003 Aug 31; 65(1):50-5. PubMed ID: 12669615
    [Abstract] [Full Text] [Related]

  • 16. Determination of HER2/neu status: a pilot study comparing HER2/neu dual in situ hybridization DNA probe cocktail assay performed on cell blocks to immunohistochemisty and fluorescence in situ hybridization performed on histologic specimens.
    Hartman AK, Gorman BK, Chakraborty S, Mody DR, Schwartz MR.
    Arch Pathol Lab Med; 2014 Apr 31; 138(4):553-8. PubMed ID: 24678687
    [Abstract] [Full Text] [Related]

  • 17. Human epidermal growth factor receptor 2 assessment in a case-control study: comparison of fluorescence in situ hybridization and quantitative reverse transcription polymerase chain reaction performed by central laboratories.
    Baehner FL, Achacoso N, Maddala T, Shak S, Quesenberry CP, Goldstein LC, Gown AM, Habel LA.
    J Clin Oncol; 2010 Oct 01; 28(28):4300-6. PubMed ID: 20697093
    [Abstract] [Full Text] [Related]

  • 18. Her-2/neu expression in breast cancer--A comparison of different diagnostic methods.
    Benöhr P, Henkel V, Speer R, Vogel U, Sotlar K, Aydeniz B, Reiser A, Neubauer H, Tabiti K, Wallwiener D, Clare SE, Kurek R.
    Anticancer Res; 2005 Oct 01; 25(3B):1895-900. PubMed ID: 16158923
    [Abstract] [Full Text] [Related]

  • 19. Monoplex LightCycler polymerase chain reaction quantitation of the HER2 gene for quality assurance of HER2/neu testing by immunohistochemistry and fluorescence in situ hybridization.
    Layfield LJ, Willmore-Payne C, Isom G, Holden JA.
    Appl Immunohistochem Mol Morphol; 2008 Dec 01; 16(6):562-7. PubMed ID: 18948825
    [Abstract] [Full Text] [Related]

  • 20. [Use of the real-time RT-PCR method for investigation of small stable RNA expression level in human epidermoid carcinoma cells A431].
    Nikitina TV, Nazarova NIu, Tishchenko LI, Tuohimaa P, Sedova VM.
    Tsitologiia; 2003 Dec 01; 45(4):392-402. PubMed ID: 14520871
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.